A new law in Maryland officially takes effect, granting veterinarians the legal protection to discuss cannabis and hemp products with pet owners as therapeutic options. Previously, practitioners faced severe professional consequences—including license suspension, revocation, or formal censure—simply for bringing up phytocannabinoids during consultations. Maryland now joins a select group of only five states providing this statutory shield.
For the pet wellness sector, this regulatory shift removes a major barrier to client education. Veterinarians can now guide dosing discussions, address toxicity concerns, and recommend specific formulations without risking their credentials. While practitioners still cannot prescribe or dispense federal Schedule I substances directly, the dialogue is finally open.
Retailers and product manufacturers stand to benefit from increased consumer confidence driven by trusted veterinary guidance—a vital step toward mainstream adoption of animal-focused cannabinoids.